ASaiM-MT: a validated and optimized ASaiM workflow for metatranscriptomics analysis within Galaxy framework.


Journal

F1000Research
ISSN: 2046-1402
Titre abrégé: F1000Res
Pays: England
ID NLM: 101594320

Informations de publication

Date de publication:
2021
Historique:
accepted: 03 02 2021
entrez: 6 9 2021
pubmed: 7 9 2021
medline: 14 9 2021
Statut: epublish

Résumé

The Human Microbiome Project (HMP) aided in understanding the role of microbial communities and the influence of collective genetic material (the 'microbiome') in human health and disease. With the evolution of new sequencing technologies, researchers can now investigate the microbiome and map its influence on human health. Advances in bioinformatics methods for next-generation sequencing (NGS) data analysis have helped researchers to gain an in-depth knowledge about the taxonomic and genetic composition of microbial communities. Metagenomic-based methods have been the most commonly used approaches for microbiome analysis; however, it primarily extracts information about taxonomic composition and genetic potential of the microbiome under study, lacking quantification of the gene products (RNA and proteins). Conversely, metatranscriptomics, the study of a microbial community's RNA expression, can reveal the dynamic gene expression of individual microbial populations and the community as a whole, ultimately providing information about the active pathways in the microbiome.  In order to address the analysis of NGS data, the ASaiM analysis framework was previously developed and made available via the Galaxy platform. Although developed for both metagenomics and metatranscriptomics, the original publication demonstrated the use of ASaiM only for metagenomics, while thorough testing for metatranscriptomics data was lacking.  In the current study, we have focused on validating and optimizing the tools within ASaiM for metatranscriptomics data. As a result, we deliver a robust workflow that will enable researchers to understand dynamic functional response of the microbiome in a wide variety of metatranscriptomics studies. This improved and optimized ASaiM-metatranscriptomics (ASaiM-MT) workflow is publicly available via the ASaiM framework, documented and supported with training material so that users can interrogate and characterize metatranscriptomic data, as part of larger meta-omic studies of microbiomes.

Identifiants

pubmed: 34484688
doi: 10.12688/f1000research.28608.1
pmc: PMC8383124
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

103

Subventions

Organisme : NCI NIH HHS
ID : U24 CA199347
Pays : United States

Informations de copyright

Copyright: © 2021 Mehta S et al.

Déclaration de conflit d'intérêts

No competing interests were disclosed.

Auteurs

Subina Mehta (S)

University of Minnesota, Twin Cities, MN, 55455, USA.

Marie Crane (M)

University of Minnesota, Twin Cities, MN, 55455, USA.

Emma Leith (E)

University of Minnesota, Twin Cities, MN, 55455, USA.

Bérénice Batut (B)

Department of Bioinformatics, University of Freiburg, Georges-Köhler-Allee 106, Freiburg, Germany.

Saskia Hiltemann (S)

Department of Pathology, Erasmus Medical Center, Rotterdam, The Netherlands.

Magnus Ø Arntzen (MØ)

Norwegian University of Life Sciences, Ås, 1430, Norway.

Benoit J Kunath (BJ)

Norwegian University of Life Sciences, Ås, 1430, Norway.

Francesco Delogu (F)

Norwegian University of Life Sciences, Ås, 1430, Norway.

Ray Sajulga (R)

University of Minnesota, Twin Cities, MN, 55455, USA.

Praveen Kumar (P)

University of Minnesota, Twin Cities, MN, 55455, USA.

James E Johnson (JE)

University of Minnesota, Twin Cities, MN, 55455, USA.

Timothy J Griffin (TJ)

University of Minnesota, Twin Cities, MN, 55455, USA.

Pratik D Jagtap (PD)

University of Minnesota, Twin Cities, MN, 55455, USA.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH